110 related articles for article (PubMed ID: 7988609)
1. The effect of subsequent myocardial damage on the expression of coxsackievirus B4 myocarditis and the development of ventricular aneurysms.
Khatib R; Khatib G; Reyes MP; Giraldo A
Eur Heart J; 1994 Aug; 15(8):1140-3. PubMed ID: 7988609
[TBL] [Abstract][Full Text] [Related]
2. The effects of pre-existing coxsackievirus B4 myocardial disease on the expression of coxsackievirus B3 myocarditis.
Khatib R; Reyes MP; Khatib G; Giraldo A
Can J Cardiol; 1993 Jun; 9(5):444-7. PubMed ID: 8394194
[TBL] [Abstract][Full Text] [Related]
3. Focal ventricular thinning caused by indomethacin in the late phase of coxsackievirus B4 murine myocarditis.
Khatib R; Reyes MP; Khatib G; Smith F; Rezkella S; Kloner RA
Am J Med Sci; 1992 Feb; 303(2):95-8. PubMed ID: 1311498
[TBL] [Abstract][Full Text] [Related]
4. Ventricular aneurysms complicating coxsackievirus group B, types 1 and 4 murine myocarditis.
El-Khatib MR; Chason JL; Lerner AM
Circulation; 1979 Feb; 59(2):412-6. PubMed ID: 215340
[TBL] [Abstract][Full Text] [Related]
5. Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage.
Kishimoto C; Kuroki Y; Hiraoka Y; Ochiai H; Kurokawa M; Sasayama S
Circulation; 1994 Jun; 89(6):2836-42. PubMed ID: 8205699
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of coxsackievirus A4, B3 and B4 infections in children.
Lee CJ; Huang YC; Yang S; Tsao KC; Chen CJ; Hsieh YC; Chiu CH; Lin TY
PLoS One; 2014; 9(2):e87391. PubMed ID: 24504149
[TBL] [Abstract][Full Text] [Related]
7. T cell-mediated immune response enhances the severity of myocarditis in secondary cardiotropic virus infection in mice.
Kishimoto C; Hiraoka Y; Takada H
Basic Res Cardiol; 2001 Sep; 96(5):439-45. PubMed ID: 11605990
[TBL] [Abstract][Full Text] [Related]
8. Role of oxygen derived free radicals in the pathogenesis of coxsackievirus B3 myocarditis in mice.
Hiraoka Y; Kishimoto C; Takada H; Kurokawa M; Ochiai H; Shiraki K; Sasayama S
Cardiovasc Res; 1993 Jun; 27(6):957-61. PubMed ID: 8221785
[TBL] [Abstract][Full Text] [Related]
9. Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis.
Kishimoto C; Kurokawa M; Ochiai H
J Mol Cell Cardiol; 2002 Sep; 34(9):1227-38. PubMed ID: 12392896
[TBL] [Abstract][Full Text] [Related]
10. Myocarditis in mice infected with Coxsackie virus B3.
Hashimoto I
Br J Exp Pathol; 1986 Oct; 67(5):737-45. PubMed ID: 3024693
[TBL] [Abstract][Full Text] [Related]
11. Effects of polyethylene glycol conjugated superoxide dismutase on coxsackievirus B3 myocarditis in mice.
Hiraoka Y; Kishimoto C; Kurokawa M; Ochiai H; Sasayama S
Cardiovasc Res; 1992 Oct; 26(10):956-61. PubMed ID: 1336713
[TBL] [Abstract][Full Text] [Related]
12. In vivo significance of T cells in the development of Coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury.
Kishimoto C; Abelmann WH
Circ Res; 1990 Sep; 67(3):589-98. PubMed ID: 1697791
[TBL] [Abstract][Full Text] [Related]
13. Viral myocarditis leading to cardiomyopathy: do cytokines contribute to pathogenesis?
Neumann DA; Lane JR; Allen GS; Herskowitz A; Rose NR
Clin Immunol Immunopathol; 1993 Aug; 68(2):181-90. PubMed ID: 8395360
[TBL] [Abstract][Full Text] [Related]
14. Studies on the pathogenesis of atrial myocarditis in mice infected with Coxsackie virus B3.
Hashimoto I; Hagiwara A
Br J Exp Pathol; 1986 Feb; 67(1):43-53. PubMed ID: 3947534
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.
Horwitz MS; La Cava A; Fine C; Rodriguez E; Ilic A; Sarvetnick N
Nat Med; 2000 Jun; 6(6):693-7. PubMed ID: 10835688
[TBL] [Abstract][Full Text] [Related]
16. Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Antiviral and anti-inflammatory effects.
Takada H; Kishimoto C; Hiraoka Y
Circulation; 1995 Sep; 92(6):1604-11. PubMed ID: 7664447
[TBL] [Abstract][Full Text] [Related]
17. LPS promotes CB3-induced myocarditis in resistant B10.A mice.
Lane JR; Neumann DA; Lafond-Walker A; Herskowitz A; Rose NR
Cell Immunol; 1991 Aug; 136(1):219-33. PubMed ID: 1647882
[TBL] [Abstract][Full Text] [Related]
18. Modification of exercise-aggravated coxsackievirus B3 murine myocarditis by T lymphocyte suppression in an inbred model.
Cabinian AE; Kiel RJ; Smith F; Ho KL; Khatib R; Reyes MP
J Lab Clin Med; 1990 Apr; 115(4):454-62. PubMed ID: 2157783
[TBL] [Abstract][Full Text] [Related]
19. Coxsackievirus B4 myocarditis and meningoencephalitis in newborn twins.
Bissel SJ; Winkler CC; DelTondo J; Wang G; Williams K; Wiley CA
Neuropathology; 2014 Oct; 34(5):429-437. PubMed ID: 24702280
[TBL] [Abstract][Full Text] [Related]
20. The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis.
Takada H; Kishimoto C; Kuroki Y; Matsushita I; Hiraoka Y; Kurokawa M; Ochiai H; Sasayama S
Heart Vessels; 1993; 8(2):59-66. PubMed ID: 8390975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
